Friale
Venture capitalActively deployingNashville · Pre-Seed–Seed
Investment thesis
The firm believes that much of the world's software will be reimagined through AI's compounding innovation cycle. They partner with exceptional founders across all verticals who are capitalizing on this opportunity. The firm takes a hands-on approach early, willing to invest before business plans are fully formed, and aims to serve as a founder-friendly investor based on their own founder experiences.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 4 of 4 portfolio companiesDigital Health ×2Healthtech ×2AI & Machine Learning ×1Biotech ×1Cloud Computing ×1Data & Infrastructure ×1Developer Tools ×1Enterprise Software ×1
HQs:United States×2India×1
Investments · 4 tracked
founders shown can be your intro pathAmbience is an AI platform that captures clinical encounters in real time, generates documentation, and suggests coding for healthcare providers across 200+ specialties. The platform helps health systems reduce clinician documentation burden, improve revenue integrity through coding accuracy, and ensure compliance.
AI & Machine LearningDigital HealthHealthtech
Fly.io provides infrastructure and platform services for deploying and running applications in a distributed, globally-connected environment. The platform serves developers and engineering teams building cloud-native applications.
Cloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareChicago, US
Michael Dwan(Founder)inJerome Gravel-Niquet(Developer + CTO)inKurt Mackey(CEO)Chris McCord(Developer)
Groww is an investment platform that allows users to buy and sell exchange-traded funds (ETFs) through an online portal. The platform serves retail investors, including beginners, seeking simplified access to diversified investment products.
FintechBengaluru, IN
Lalit Keshre(Founder/CEO)inIshan Bansal(Founder)inHarsh Jain(Founder/COO)inNeeraj Singh(Founder)in
BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection. The company focuses on making molecular diagnostics accurate, fast, and accessible to patients.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Oguzhan Atay, PhD(Co-Founder, CEO, and Board Chair)David Tsao, PhD(Co-Founder, CTO, and Board Member)Oguzhan Atay(Founder)inDavid Tsao(Founder/CTO)in
Frequently asked questions
- What stage does Friale invest at?
- Friale invests at the Pre-Seed, Seed stages.
- What sectors does Friale focus on?
- Friale focuses on AI & Machine Learning, Sector Agnostic.
- Where is Friale located?
- Friale is headquartered in Nashville, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Clear Ventures is a Silicon Valley venture capital firm focused on early-stage investing in frontier technology and services. The firm manages $335 million in capital and provides seed funding, strategic connections, and company-building guidance to exceptional startup teams.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Felicis Ventures is a venture capital firm investing in early-stage founders building iconic companies. The firm prioritizes founder partnership, backing companies primarily at Seed and Series A stages with a focus on long-term support and alignment.
First Round is a venture capital firm focused on partnering with founders at the earliest stages of company formation, providing active partners with founder experience alongside functional expertise including go-to-market strategy and recruitment support.